北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 肾脏内科  > 期刊论文
学科主题: 临床医学
题名:
Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study
作者: Wang, H. Y.1; Cui, T. G.; Hou, F. F.; Ni, Z. H.; Chen, X. M.; Lu, F. M.; Xu, F. F.; Yu, X. Q.; Zhang, F. S.; Zhao, X. Z.; Zhao, M. H.; Wang, G. B.; Qian, J. Q.; Cai, G. Y.; Zhu, T. Y.; Wang, Y. H.; Jiang, Z. P.; Li, Y. N.; Mei, C. L.; Zou, W. Z.; China Leflunomide Lupus Nephritis
关键词: leflunomide ; lupus nephritis ; multi-centre observational study
刊名: LUPUS
发表日期: 2008
DOI: 10.1177/0961203308089408
卷: 17, 期:7, 页:638-644
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Rheumatology
研究领域[WOS]: Rheumatology
关键词[WOS]: ACTIVE RHEUMATOID-ARTHRITIS ; IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE ; DOUBLE-BLIND ; IN-VIVO ; ERYTHEMATOSUS ; PLACEBO ; SUPPRESSION ; MECHANISM ; EFFICACY ; SAFETY
英文摘要:

To evaluate the efficacy and safety of leflunomide in the treatment of proliferative lupus nephritis, a prospective multi-centre observational study was conducted. Patients with biopsy proven proliferative lupus nephritis were assigned to receive either leflunomide or cyclophosphamide with concomitant prednisone. Leflunomide was given orally with a loading dose of I mg/kg/day for 3 days followed by 30 mg/day. Intravenous cyclophosphamide was administered monthly at a dose of 0.5 g/m(2) of body-surface area. A total of 110 patients were enrolled, 70 in the leflunomide group and 40 in the cyclophosphamide group. The complete remission rate in the leflunomide group was 21% and partial remission rate 52%, as compared with 18% and 55%, respectively, in the cyclophosphamide group. Renal parameters and systemic lupus erythematosus disease activity index improved significantly and similarly in both groups. Serum creatinine decreased or stabilized in both treatment groups. No significant difference was noted with respect to clinical outcome between groups. Repeat biopsy also showed a significant reduction of active lesions in kidney pathology after 6 months of leflunomide treatment. Major adverse events, similar in both treatment groups, included infection, alopecia and hypertension. Leflunomide, compared with cyclophosphamide, in combination with prednisone was effective in the induction therapy of proliferative lupus nephritis and was generally well-tolerated.

语种: 英语
WOS记录号: WOS:000257934200006
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/66564
Appears in Collections:北京大学第一临床医学院_肾脏内科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Hosp 1, Dept Med, Div Renal, Beijing 100034, Peoples R China
2.So Med Univ, Nanfang Hosp, Div Nephrol, Guangzhou, Guangdong, Peoples R China
3.Shanghai Jiao Tong Univ, Renji Hosp, Div Renal, Shanghai, Peoples R China
4.Chinese Gen Hosp PLA, Dept Nephrol, Kidney Ctr, Beijing, Peoples R China
5.Chinese Gen Hosp PLA, Key Lab PLA, Beijing, Peoples R China
6.Fudan Univ, Div Renal, Huashan Hosp, Shanghai 200433, Peoples R China
7.Wenzhou Med Coll, Div Renal, Affiliated Hosp 1, Wenzhou, Peoples R China
8.Sun Yat Sen Univ, Affiliated Hosp 1, Div Renal, Guangzhou 510275, Guangdong, Peoples R China
9.Harbin Med Coll, Affiliated Hosp 2, Dept Rheumatol, Harbin, Peoples R China
10.Shanghai Changzheng Hosp, Dept Nephrol, Shanghai, Peoples R China

Recommended Citation:
Wang, H. Y.,Cui, T. G.,Hou, F. F.,et al. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study[J]. LUPUS,2008,17(7):638-644.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Wang, H. Y.]'s Articles
[Cui, T. G.]'s Articles
[Hou, F. F.]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Wang, H. Y.]‘s Articles
[Cui, T. G.]‘s Articles
[Hou, F. F.]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit
所有评论 (0)
暂无评论
 
评注功能仅针对注册用户开放,请您登录
您对该条目有什么异议,请填写以下表单,管理员会尽快联系您。
内 容:
Email:  *
单位:
验证码:   刷新
您在IR的使用过程中有什么好的想法或者建议可以反馈给我们。
标 题:
 *
内 容:
Email:  *
验证码:   刷新

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace